The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized, double-blind study of gefitinib in combination with anlotinib or placebo in previously untreated patients with EGFR mutation-positive advanced non-small cell lung cancer (FL-ALTER).
 
Li Zhang
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Qitao Yu
No Relationships to Disclose
 
Di Wu
No Relationships to Disclose
 
Yingcheng Lin
No Relationships to Disclose
 
Hua Zhang
No Relationships to Disclose
 
Junfei Zhu
No Relationships to Disclose
 
Guowu Wu
No Relationships to Disclose
 
Bin Lan
No Relationships to Disclose
 
Zeqiang Zhou
No Relationships to Disclose
 
Zibing WANG
No Relationships to Disclose
 
Xiaolin Lei
No Relationships to Disclose
 
Haifeng Lin
No Relationships to Disclose
 
Xiaohua HU
No Relationships to Disclose
 
Suming Pan
No Relationships to Disclose